Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is proud to announce its 2024 global Request for Proposals for its Breakthrough Research and Innovation in Drug Development Grants (BRIDGe).
BRIDGe awards are designed to support academic researchers by providing funding and defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients. Projects eligible for BRIDGe awards include early lead optimization and IND-enabling studies, using small molecule approaches, anywhere in the world. Biologicals, including peptides or antibodies, oligonucleotides, cell and gene therapy applications and medical devices are not eligible at this time. Drug repurposing approaches are also not eligible during this funding cycle.
Please see attached documents for the 
details of the funding opportunity and also a pre-proposal template. To apply, send Deanna Scarcella (des4016@med.cornell.edu) a NON-CONFIDENTIAL (make sure to EXCLUDE any unpublished data or information) pre-proposal by Friday, March 22, 2024, which will be reviewed by the CTL. CTL will coordinate submitting the pre-proposal by the deadline of Fri, Mar 29. Contact Deanna if you have any questions.